Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Japan Medical Dynamic MarketingFRA:JMD -2.87%81 5-Year Yield-on-Cost % is 2.94 as of Jul. 27, 2026, which is 156% above its 10-year median of 1.15. GuruFocus rates FRA:JMD with a GF Score™ of 81/100 and a GF Value™ of €3.38. The stock has 12 warning signs investors should review. Among 323 Medical Devices & Instruments companies, Japan Medical Dynamic Marketing ranks better than 54.49% on this metric.
The historical rank and industry rank for Japan Medical Dynamic Marketing's 5-Year Yield-on-Cost % or its related term are showing as below:
FRA:JMD'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.53 Med: 1.15 Max: 4.95
Current: 2.94
During the past 13 years, Japan Medical Dynamic Marketing's highest Yield on Cost was 4.95. The lowest was 0.53. And the median was 1.15.
FRA:JMD's 5-Year Yield-on-Cost % is ranked better than 54.49% of 323
companies
in the Medical Devices & Instruments industry
Industry Median: 2.51
vs FRA:JMD: 2.94
Japan Medical Dynamic Marketing (FRA:JMD) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Japan Medical Dynamic Marketing 5-Year Yield-on-Cost % Related Terms
FRA:JMD vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Japan Medical Dynamic Marketing's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Medical Dynamic Marketing 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Japan Medical Dynamic Marketing's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Japan Medical Dynamic Marketing's 5-Year Yield-on-Cost % falls into.
Japan Medical Dynamic Marketing 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Japan Medical Dynamic Marketing (FRA:JMD) has a 5-Year Yield-on-Cost % of 2.94 as of Jul. 27, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Japan Medical Dynamic Marketing and its competitors. This is 156% above median its historical median of 1.15. Over the past decade, Japan Medical Dynamic Marketing's 5-Year Yield-on-Cost % has ranged from 0.53 to 4.95. According to the industry distribution chart, Japan Medical Dynamic Marketing ranks #147 out of 323 companies in the Medical Devices & Instruments industry, placing it in the top 45.5%.
Is Japan Medical Dynamic Marketing's 5-Year Yield-on-Cost % too high?
Japan Medical Dynamic Marketing's current 5-Year Yield-on-Cost % of 2.94 is 156% above median its 10-year median of 1.15. Over the past 10 years, this metric has ranged from a low of 0.53 to a high of 4.95. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.51. Japan Medical Dynamic Marketing's value of 2.94 is 17.1% above this industry median. Based on the distribution chart, Japan Medical Dynamic Marketing ranks #147 out of 323 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Japan Medical Dynamic Marketing has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Japan Medical Dynamic Marketing's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Japan Medical Dynamic Marketing ranks #147 out of 323 companies for 5-Year Yield-on-Cost %. This puts Japan Medical Dynamic Marketing in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.51. Japan Medical Dynamic Marketing's value of 2.94 is 17.1% above this benchmark. Historically, Japan Medical Dynamic Marketing's own 5-Year Yield-on-Cost % has ranged from 0.53 to 4.95 over the past decade. While the company's 10-year median is 1.15 vs. the industry median of 2.51, Japan Medical Dynamic Marketing has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.51, based on 323 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Japan Medical Dynamic Marketing's current 5-Year Yield-on-Cost % of 2.94 is 17.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Japan Medical Dynamic Marketing and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Medical Dynamic Marketing's current 5-Year Yield-on-Cost % is 2.94, which is 156% above median its own 10-year median of 1.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Medical Dynamic Marketing stock overvalued right now?
Japan Medical Dynamic Marketing (FRA:JMD) has a current 5-Year Yield-on-Cost % of 2.94. The stock's GF Value™ is €3.38, compared to a current price of €4.74 — trading 40.2% above its estimated fair value. The current 5-Year Yield-on-Cost % is 2.94, which is 156% above median its 10-year median of 1.15 and 17.1% above the Medical Devices & Instruments industry median of 2.51. Japan Medical Dynamic Marketing's overall GF Score™ is 81/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Japan Medical Dynamic Marketing (FRA:JMD), the current 5-Year Yield-on-Cost % is 2.94 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Medical Dynamic Marketing (FRA:JMD) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Medical Dynamic Marketing stock appears to be overvalued.
The current stock price of €4.74 is trading 40.2% above its estimated GF Value™ of €3.38.
Key valuation signals for FRA:JMD:
5-Year Yield-on-Cost %: 2.94 (156% above median its 10-year median of 1.15)
GF Value™: €3.38 vs. price of €4.74 (40.2% above fair value)
Industry Position: 17.1% above the Medical Devices & Instruments median (#147 of 323)
No single metric tells the full story. See the FRA:JMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Medical Dynamic Marketing Business Description
Japan Medical Dynamic Marketing Inc is a Japan-based medical equipment manufacturer. The company is engaged in the development and sale of advanced medical devices. Products offered by the company include trauma devices, joint prostheses, spinal fixation devices, and artificial bone fillers. It caters its products to medical professionals and major hospitals throughout Japan. The company is also engaged in the import and sale of medical devices.
81GF Score
Get the complete analysis for FRA:JMD
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:JMD has been successfully added to your 
